UBS Group’s Zogenix, Inc. ZGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-70,000
Closed -$1.14M 11622
2021
Q4
$1.14M Hold
70,000
﹤0.01% 4267
2021
Q3
$1.06M Buy
70,000
+20,000
+40% +$312K ﹤0.01% 4154
2021
Q2
$864K Hold
50,000
﹤0.01% 4295
2021
Q1
$976K Hold
50,000
﹤0.01% 4273
2020
Q4
$1M Hold
50,000
﹤0.01% 4032
2020
Q3
$897K Buy
50,000
+41,500
+488% +$1.02M ﹤0.01% 3720
2020
Q2
$230K Buy
+8,500
New +$234K ﹤0.01% 4711
2018
Q4
Sell
-159,800
Closed -$7.93M 8704
2018
Q3
$7.93M Buy
+159,800
New +$8.13M ﹤0.01% 1967
2015
Q1
Sell
-613
Closed -$7K 9991
2014
Q4
$7K Buy
+613
New +$6.07K ﹤0.01% 8768

UBS Group's ZGNX Position: Q1 2022 in Review

UBS Group sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 2,221 shares — an estimated $36K sold.

UBS Group first reported a position in ZGNX in Q4 2014 and held it in 29 quarters. The position peaked at $3.18M in Q3 2017. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.

  • UBS Group reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
  • UBS Group sold 2,221 Zogenix, Inc. shares in Q1 2022, an estimated $36K.
  • UBS Group first reported a position in Zogenix, Inc. in Q4 2014 and held it in 29 quarters.
  • UBS Group's Zogenix, Inc. position peaked at $3.18M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.